Yemaachi Biotech
yemaachi.comCancer innovation shaped by Africa — for the world
Health & Wellnessbiotechcancergenomicsprecision-oncologyafricaclinical-researchdrug-development
About
Yemaachi Biotech is an African-rooted biotechnology company building the world's most diverse cancer bio-database through clinical genomic research across Africa. Their goal is to develop next-generation cancer drugs that are effective across diverse populations, advancing inclusive precision oncology. The company is supported by a global network of partners from the public, private, and non-profit sectors.
Problem
Current cancer drugs and genomic databases lack diversity, making treatments less effective for African and other underrepresented populations.
For
oncology researchers, pharmaceutical companies, and healthcare institutions focused on diverse populations
How it works
Yemaachi conducts clinical genomic research across multiple cancer types in Africa to build a robust cancer knowledge base used to develop more inclusive cancer therapies.
Business model
unknown
Status
launched
Company
Yemaachi Biotech